29 April 2021 -
New CEO at active ingredient specialist AMW to drive international expansion
The successful specialty pharmaceutical company AMW GmbH is expanding its management team and bringing experience and leadership to its new CEO, Dr. Konstantin Petropoulus. With his many years of expertise, the molecular biologist with an MBA is to help strengthen AMW’s global presence. In addition, Dr. Petropoulus will expand the drug delivery system pipeline with both proprietary products and collaborative developments. The aim is to provide patients worldwide with even better treatment options, for example for cancer.
More information: t1p.de